Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000412951

Medchemexpress LLC Trihexyphenidyl (hydrochloride) | 52-49-3 | MFCD00058212 | 99.9% | 1 ML
SDP

Catalog No. 5000412951
Encompass_Preferred

Trihexyphenidyl hydrochloride is a selective and orally active M1 muscarinic receptor antagonist with an IC50 of 3.7 nM for rat cerebral cortex M1 muscarinic receptors. It modulates cholinergic activity by countering acetylcholine supersensitivity in neural pathways. The compound has been shown to improve movement disorder and inhibit McN-A-343 (HY-107648)-induced pressor responses, vagally-induced bradycardia, and vasodilatation. Trihexyphenidyl hydrochloride is utilized in the research of Parkinson's disease.

  • Selective and orally active M1 muscarinic receptor antagonist.
  • Modulates cholinergic activity, countering acetylcholine supersensitivity in neural pathways.
  • Improves movement disorder.
  • Inhibits McN-A-343 (HY-107648)-induced pressor responses.
  • Inhibits vagally-induced bradycardia and vasodilatation.
  • Can be used for the research of Parkinson's disease.

Catalog No. 50-004-12951 Supplier Medchemexpress LLC Supplier No. HYB127710MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Trihexyphenidyl hydrochloride is a selective and orally active M1 muscarinic receptor antagonist with an IC50 of 3.7 nM for rat cerebral cortex M1 muscarinic receptors. It modulates cholinergic activity by countering acetylcholine supersensitivity in neural pathways. The compound has been shown to improve movement disorder and inhibit McN-A-343 (HY-107648)-induced pressor responses, vagally-induced bradycardia, and vasodilatation. Trihexyphenidyl hydrochloride is utilized in the research of Parkinson's disease.

  • Selective and orally active M1 muscarinic receptor antagonist.
  • Modulates cholinergic activity, countering acetylcholine supersensitivity in neural pathways.
  • Improves movement disorder.
  • Inhibits McN-A-343 (HY-107648)-induced pressor responses.
  • Inhibits vagally-induced bradycardia and vasodilatation.
  • Can be used for the research of Parkinson's disease.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.